Literature DB >> 23322642

Striking intrafamilial phenotypic variability in Aicardi-Goutières syndrome associated with the recurrent Asian founder mutation in RNASEH2C.

Julie Vogt1, Shakti Agrawal, Zala Ibrahim, Taunton R Southwood, Sunny Philip, Lesley Macpherson, Malini V Bhole, Yanick J Crow, Christine Oley.   

Abstract

Aicardi-Goutières syndrome (AGS) is an encephalopathy of early childhood which is most commonly inherited as an autosomal recessive trait. The disorder demonstrates significant genetic heterogeneity with causative mutations in five genes identified to date. Although most patients with AGS experience a severe neonatal or infantile presentation, poor neurodevelopmental outcome and reduced survival, clinical variability in the onset and severity of the condition is being increasingly recognized. A later presentation with a more variable effect on development, morbidity and mortality has been particularly observed in association with mutations in SAMHD1 and RNASEH2B. In contrast, the recurrent c.205C > T (p.R69W) RNASEH2C Asian founder mutation has previously only been identified in children with a severe AGS phenotype. Here, to our knowledge, we present the first report of marked phenotypic variability in siblings both harboring this founder mutation in the homozygous state. In this family, one female child had a severe AGS phenotype with an onset in infancy and profound developmental delay, whilst an older sister was of completely normal intellect with a normal head circumference and was only diagnosed because of the presence of chilblains and a mild hemiplegia. An appreciation of intrafamilial phenotypic expression is important in the counseling of families considering prenatal diagnosis, and may also be relevant to the assessment of efficacy in future clinical trials. In addition, marked phenotypic variation raises the possibility that more mildly affected patients are not currently identified.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23322642     DOI: 10.1002/ajmg.a.35712

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

Review 1.  Aicardi-Goutières syndrome and the type I interferonopathies.

Authors:  Yanick J Crow; Nicolas Manel
Journal:  Nat Rev Immunol       Date:  2015-06-05       Impact factor: 53.106

2.  Aicardi-Goutières syndrome: unusual neuro-radiological manifestations.

Authors:  Ghada M H Abdel-Salam; Mohamed S Abdel-Hamid; Shaimaa A Mohammad; Sherif F Abdel-Ghafar; Doaa R Soliman; Hala T El-Bassyouni; Laila Effat; Maha S Zaki
Journal:  Metab Brain Dis       Date:  2017-03-23       Impact factor: 3.584

Review 3.  Therapies in Aicardi-Goutières syndrome.

Authors:  Y J Crow; A Vanderver; S Orcesi; T W Kuijpers; G I Rice
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

4.  Diagnosis of Aicardi-Goutières Syndrome in Adults: A Case Series.

Authors:  Gonçalo Videira; Maria João Malaquias; Inês Laranjinha; Ricardo Martins; Ricardo Taipa; Marina Magalhães
Journal:  Mov Disord Clin Pract       Date:  2020-02-17

5.  Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.

Authors:  Yanick J Crow; Diana S Chase; Johanna Lowenstein Schmidt; Marcin Szynkiewicz; Gabriella M A Forte; Hannah L Gornall; Anthony Oojageer; Beverley Anderson; Amy Pizzino; Guy Helman; Mohamed S Abdel-Hamid; Ghada M Abdel-Salam; Sam Ackroyd; Alec Aeby; Guillermo Agosta; Catherine Albin; Stavit Allon-Shalev; Montse Arellano; Giada Ariaudo; Vijay Aswani; Riyana Babul-Hirji; Eileen M Baildam; Nadia Bahi-Buisson; Kathryn M Bailey; Christine Barnerias; Magalie Barth; Roberta Battini; Michael W Beresford; Geneviève Bernard; Marika Bianchi; Thierry Billette de Villemeur; Edward M Blair; Miriam Bloom; Alberto B Burlina; Maria Luisa Carpanelli; Daniel R Carvalho; Manuel Castro-Gago; Anna Cavallini; Cristina Cereda; Kate E Chandler; David A Chitayat; Abigail E Collins; Concepcion Sierra Corcoles; Nuno J V Cordeiro; Giovanni Crichiutti; Lyvia Dabydeen; Russell C Dale; Stefano D'Arrigo; Christian G E L De Goede; Corinne De Laet; Liesbeth M H De Waele; Ines Denzler; Isabelle Desguerre; Koenraad Devriendt; Maja Di Rocco; Michael C Fahey; Elisa Fazzi; Colin D Ferrie; António Figueiredo; Blanca Gener; Cyril Goizet; Nirmala R Gowrinathan; Kalpana Gowrishankar; Donncha Hanrahan; Bertrand Isidor; Bülent Kara; Nasaim Khan; Mary D King; Edwin P Kirk; Ram Kumar; Lieven Lagae; Pierre Landrieu; Heinz Lauffer; Vincent Laugel; Roberta La Piana; Ming J Lim; Jean-Pierre S-M Lin; Tarja Linnankivi; Mark T Mackay; Daphna R Marom; Charles Marques Lourenço; Shane A McKee; Isabella Moroni; Jenny E V Morton; Marie-Laure Moutard; Kevin Murray; Rima Nabbout; Sheela Nampoothiri; Noemi Nunez-Enamorado; Patrick J Oades; Ivana Olivieri; John R Ostergaard; Belén Pérez-Dueñas; Julie S Prendiville; Venkateswaran Ramesh; Magnhild Rasmussen; Luc Régal; Federica Ricci; Marlène Rio; Diana Rodriguez; Agathe Roubertie; Elisabetta Salvatici; Karin A Segers; Gyanranjan P Sinha; Doriette Soler; Ronen Spiegel; Tommy I Stödberg; Rachel Straussberg; Kathryn J Swoboda; Mohnish Suri; Uta Tacke; Tiong Y Tan; Johann te Water Naude; Keng Wee Teik; Maya Mary Thomas; Marianne Till; Davide Tonduti; Enza Maria Valente; Rudy Noel Van Coster; Marjo S van der Knaap; Grace Vassallo; Raymon Vijzelaar; Julie Vogt; Geoffrey B Wallace; Evangeline Wassmer; Hannah J Webb; William P Whitehouse; Robyn N Whitney; Maha S Zaki; Sameer M Zuberi; John H Livingston; Flore Rozenberg; Pierre Lebon; Adeline Vanderver; Simona Orcesi; Gillian I Rice
Journal:  Am J Med Genet A       Date:  2015-01-16       Impact factor: 2.802

Review 6.  Type I interferonopathies--an expanding disease spectrum of immunodysregulation.

Authors:  Min Ae Lee-Kirsch; Christine Wolf; Stefanie Kretschmer; Axel Roers
Journal:  Semin Immunopathol       Date:  2015-05-22       Impact factor: 11.759

Review 7.  Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas.

Authors:  Virginie S E Jean-Baptiste; Chang-Qing Xia; Michael J Clare-Salzler; Marc S Horwitz
Journal:  EBioMedicine       Date:  2017-06-21       Impact factor: 8.143

8.  Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies.

Authors:  Yanfeng Zhang; Jirong Long; Wei Lu; Xiao-Ou Shu; Qiuyin Cai; Ying Zheng; Chun Li; Bingshan Li; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01-27       Impact factor: 4.254

9.  Ribonuclease H2 mutations induce a cGAS/STING-dependent innate immune response.

Authors:  Karen J Mackenzie; Paula Carroll; Laura Lettice; Žygimantė Tarnauskaitė; Kaalak Reddy; Flora Dix; Ailsa Revuelta; Erika Abbondati; Rachel E Rigby; Björn Rabe; Fiona Kilanowski; Graeme Grimes; Adeline Fluteau; Paul S Devenney; Robert E Hill; Martin Am Reijns; Andrew P Jackson
Journal:  EMBO J       Date:  2016-02-22       Impact factor: 11.598

10.  Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.

Authors:  Xinfeng Guo; Clayton A Wiley; Richard A Steinman; Yi Sheng; Beihong Ji; Junmei Wang; Liyong Zhang; Tony Wang; Mazen Zenatai; Timothy R Billiar; Qingde Wang
Journal:  J Neuroinflammation       Date:  2021-07-31       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.